Skip to main content

Table 5 Dose of Palbociclib-based treatment

From: Palbociclib plus endocrine therapy in hormone receptor-positive and HER2 negative metastatic breast cancer: a multicenter real-world study in the northwest of China

Start dose of Palbociclib (mg/day)

 

 Subtotal

211(100)

  Start at 125

181(85.8)

  Start at 100

29(13.7)

  Start at 75

1(0.5)

Dose reduction (mg/day)

 

 Subtotal

32(15.2)

  From 125 to 100

21(10.0)

  From 100 to 75

11(5.2)

  1. Values are presented as number (%) unless otherwise indicated